Experience

Cooley Advises Uber on $2.25 Billion Investment-Grade Bond Offering

September 8, 2025

Cooley advised Uber Technologies (NYSE: UBER), a technology platform that uses a massive network, leading technology, operational excellence and product expertise to power movement from point A to point B, on its $2.25 billion investment-grade bond offering.

Read more

Related contacts

Mischi a Marca
Partner, San Francisco
Jason Savich
Partner, San Francisco
Matt Kong
Associate, San Francisco
Eric Blanchard
Partner, Boston
Carlos Ramirez
Partner, San Diego
Siana Lowrey
Of Counsel
David Peinsipp
Partner, San Francisco
Talya Kornitzer
Associate, New York
Eileen Marshall
Partner, Washington, DC
Timothy Shapiro
Partner, Palo Alto
Michael Pelle
Associate, New York
Francis Wheeler
Senior Counsel, Colorado
Jack Jones
Special Counsel, London
Helena Ferreira
Associate, Boston
Peter A. Haddad
Associate, San Diego
Jacob B. Hanna
Associate, San Francisco
Yoni Horn
Associate, Santa Monica
Xueqing Li
Associate, San Francisco
Marjorie O'Neill
Associate, San Francisco
Eric Steiner
Paralegal Specialist, San Francisco

Related Practices & Industries

Shoulder Innovations Announces $75 Million IPO

July 31, 2025

Cooley advised the underwriters of Shoulder Innovations, a medical technology company exclusively focused on transforming the shoulder surgical care market, in connection with Shoulder Innovations’ $75 million initial public offering (IPO).

Read more

Related contacts

Denny Won
Partner, San Francisco
Charlie Kim
Partner, San Diego
Kristin VanderPas
Partner, San Francisco
David Peinsipp
Partner, San Francisco
Xander Lee
Partner, Santa Monica
Barbara Mirza
Partner, Santa Monica
Phil Mitchell
Partner, New York
Scott Weston
Partner, Boston
Kassity L. Mai
Special Counsel, Reston
Randy Sabett
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Valerie Sapozhnikova
Associate, Los Angeles
Alex Hammer
Associate, San Francisco
Allison Kutner
Associate, New York
Sunny J. Levine
Associate, Colorado
Ryan Lewis
Associate, Colorado
Sarah Miller
Associate, New York
Marjorie O'Neill
Associate, San Francisco
Amanda Pacheco
Associate, Palo Alto

Related Practices & Industries

Septerna Announces Upsized $331.2 Million IPO

November 1, 2024

Cooley advised the underwriters of Septerna, a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery, on its upsized $331.2 million initial public offering.

Read more

Related contacts

Denny Won
Partner, San Francisco
Charlie Kim
Partner, San Diego
Kristin VanderPas
Partner, San Francisco
David Peinsipp
Partner, San Francisco
Claire Keast-Butler
Co-Partner in Charge – London, London
Xander Lee
Partner, Santa Monica
Barbara Mirza
Partner, Santa Monica
Phil Mitchell
Partner, New York
Dr. Madhuri Roy
Partner, Palo Alto
Randy Sabett
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Grady Chang
Associate, Santa Monica
Megan Drill
Associate, San Diego
Allison Kutner
Associate, New York
Sarah Miller
Associate, New York
Marjorie O'Neill
Associate, San Francisco
Minkyu Park
Special Counsel, New York
Dr. Mark Westwood
Associate, Palo Alto
Hardy Zhou
Associate, New York

Related Practices & Industries

Mirum Pharmaceuticals – $275 Million Convertible Senior Notes Offering

April 13, 2023

Cooley advised Mirum Pharmaceuticals on its $275 million aggregate principal amount of 4.00% convertible senior notes due 2029. Mirum is a biopharmaceutical company dedicated to transforming the treatment of rare liver diseases. Jason Kent and Jason Savich led the Cooley team.

Related contacts

Jason Kent
Partner, New York
Jason Savich
Partner, San Francisco
Stevie Yu
Associate, New York
Marjorie O'Neill
Associate, San Francisco
Nicholaus E. Johnson
Associate, San Diego
Winda Fung
Associate, Santa Monica

Related Practices & Industries

Pliant Therapeutics – $230.0 Million Follow-on Offering

August 24, 2022

Cooley advised the underwriters in Pliant Therapeutics’ $230.0 million follow-on offering of 12,432,432 shares of common stock at a public offering price of $18.50 per share. Pliant is a clinical-stage biotechnology company discovering and developing novel therapies for the treatment of fibrosis. Partners Denny Won, Charlie Kim, Kristin VanderPas and Dave Peinsipp led the Cooley team.

Related contacts

Denny Won
Partner, San Francisco
Charlie Kim
Partner, San Diego
Kristin VanderPas
Partner, San Francisco
David Peinsipp
Partner, San Francisco
Valerie Sapozhnikova
Associate, Los Angeles
Madison (JJ) Meng
Associate, San Francisco
Marjorie O'Neill
Associate, San Francisco

Related Practices & Industries

View more

Admissions and credentials

California

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.